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Abstract
Cys-loop receptors (CLR) are pentameric ligand-gated ion channels that mediate fast excitatory or inhibitory transmission in
the nervous system. Strychnine and d-tubocurarine (d-TC) are neurotoxins that have been highly instrumental in decades of
research on glycine receptors (GlyR) and nicotinic acetylcholine receptors (nAChR), respectively. In this study we addressed
the question how the molecular recognition of strychnine and d-TC occurs with high affinity and yet low specificity towards
diverse CLR family members. X-ray crystal structures of the complexes with AChBP, a well-described structural homolog of
the extracellular domain of the nAChRs, revealed that strychnine and d-TC adopt multiple occupancies and different ligand
orientations, stabilizing the homopentameric protein in an asymmetric state. This introduces a new level of structural
diversity in CLRs. Unlike protein and peptide neurotoxins, strychnine and d-TC form a limited number of contacts in the
binding pocket of AChBP, offering an explanation for their low selectivity. Based on the ligand interactions observed in
strychnine- and d-TC-AChBP complexes we performed alanine-scanning mutagenesis in the binding pocket of the human
a1 GlyR and a7 nAChR and showed the functional relevance of these residues in conferring high potency of strychnine and
d-TC, respectively. Our results demonstrate that a limited number of ligand interactions in the binding pocket together with
an energetic stabilization of the extracellular domain are key to the poor selective recognition of strychnine and d-TC by
CLRs as diverse as the GlyR, nAChR, and 5-HT3R.
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Introduction
Strychnine and d-TC (Figure 1A) are alkaloids from poisonous
plants. Strychnine exerts its lethal effects by antagonizing
inhibitory glycine receptors (GlyR) in the central nervous system.
Intoxication with strychnine causes muscle spasms, convulsions
and eventually leads to death by respiratory paralysis. Clinical use
of strychnine is restricted, but it is still applied as a rodenticide.
Unlike strychnine, curare is not a homogenous substance but a
cocktail of compounds derived from different plant families. One
of the best-described active compounds is d-tubocurarine (d-TC), a
quaternary head-to-tail tetrahydroisoquinoline that potently an-
tagonizes the action of acetylcholine on muscle-type [1,2] and
neuronal [3,4] nAChRs. Intoxication leads to complete paralysis
of all skeletal muscles and death by respiratory paralysis. In the
Western world d-TC analogs have been used in anesthesia as a
muscle relaxant during surgery.
In addition to their clinical use d-TC and strychnine have been
essential molecular tools for the pharmacological characterization
of different cys-loop receptors (CLR). d-TC and strychnine act as
competitive antagonists with very high affinity for nAChRs and
GlyRs, respectively. However, their actions extend to other
members of the CLR family. For example, d-TC antagonizes the
action of serotonin on 5-HT3 receptors [5,6]. Strychnine mainly
blocks the inhibitory GlyR but also antagonizes certain GABAA
receptors [7] and nAChRs [8,9]. This mode of action strikingly
differs from that of protein and peptide neurotoxins such as a-
bungarotoxin and a-conotoxins, which in general bind with high
affinity and specificity to distinct subtypes of nAChRs, and not to
other CLRs.
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Our understanding of the molecular action of d-TC and
strychnine derives from decades of research including ligand
competition assays, receptor labeling, electrophysiological studies,
and site-directed mutagenesis [1,2,5,10–19]. Mutational analysis
of the homomeric a1 GlyR revealed several residues in the
extracellular ligand-binding domain important for agonist and
antagonist binding (reviewed in [20,21]). Additional evidence for
amino acids involved in strychnine binding comes from the
identification of a single amino acid substitution in the neonatal-
specific a2 GlyR that renders newborn rats insensitive to
strychnine poisoning [22]. Recently, Grudzinska et al. described
the contribution of several key residues to strychnine binding in
the b-subunit of heterooligomeric a1b GlyR [23]. Mutational
analysis of conserved aromatic residues of nAChRs demonstrated
their importance for binding of curariform antagonists [1,10].
Recently, Gao et al. [24] characterized an extensive set of mutants
in acetylcholine binding protein (AChBP), a structural and
functional homolog of the extracellular domain of the nAChR
(Figure 1B) [25]. Mutagenesis experiments in AChBP [24] and
muscle-type nAChR [26] were based on the ligand-receptor
contacts observed in docking simulations of d-TC- and metocurine-
complexes with AChBP.
In this study we addressed a question that is fundamental to
CLR function and that is how the binding cavities of CLRs as
diverse as the nAChR, GlyR, and 5-HT3R recognize inhibitors
such as strychnine and d-TC with high affinity but low specificity.
In particular, we investigated the molecular determinants of ligand
recognition of these inhibitors. For this, we co-crystallized AChBP
with d-TC and strychnine. These structures enabled identification
of the ligand-binding modes and contacts formed in the receptor
pocket and, complemented with computational simulations,
revealed the dynamic effects of antagonist binding. Mutagenesis
and electrophysiological recordings of human GlyRs and nAChRs
were then used to test the functional relevance and predictive
value of these models. Together, our study provides a blueprint for
the molecular recognition of poorly selective alkaloid antagonists
at different CLRs.
Results
X-Ray Crystal Structures of Aplysia AChBP in Complexes
with d-TC and Strychnine
To investigate the validity of AChBP as a model to understand
binding of strychnine and d-TC to CLRs we determined the
affinity of these ligands for Aplysia californica AChBP (Ac-AChBP)
[27], a preferred homolog for structural studies. From competitive
binding assays with 3H-epibatidine and 3H-methyllycaconitine we
calculated Ki-values for strychnine and d-TC (Table 1). The
affinity of strychnine for Ac-AChBP (Ki = 38.063.3 nM) is more
than 100-fold higher than for a7 nAChR (Ki = 4,8546133 nM)
and is actually close to the high affinity of strychnine reported for
the a1 GlyR (Ki = 1662 nM). This suggests that AChBP is an
appropriate model to predict binding of strychnine to the nAChR
as well as to the GlyR. Similarly, we found that the affinity of d-TC
for Ac-AChBP (Ki = 509.2638.0 nM) is in the same range as the
reported values for binding of d-TC at muscle nAChR [1] and the
mouse 5-HT3R [28]. Together, the high affinity binding of
strychnine and d-TC makes AChBP suitable for structural studies
of ligand-binding modes of these ligands by X-ray crystallography.
Crystallization of Aplysia AChBP with strychnine or d-TC gave
co-crystals that diffracted at 1.9 A˚ and 2.0 A˚ resolution,
respectively, and provided a highly detailed view of their binding
modes. Crystallographic data are reported in Table S1. The
crystal structure of Aplysia AChBP in complex with strychnine
contains 1 pentamer in the asymmetric unit (Figure 2A). Similar to
other AChBP co-crystal structures (e.g. pdb code 2c9t) the
symmetry packing in this crystal form is characterized by an
interaction of neighboring pentamers through an interface formed
by two C loops (Figure 2A). Inspection of simple difference
electron density unambiguously revealed the ligand orientation in
all five binding sites of the pentamer (Figure 2B). Remarkably, one
of the two C loops involved in forming a crystal contact is in a
more extended conformation and reveals electron density for a
second strychnine molecule in the same binding site. The second
strychnine molecule has a B-factor = 60.67 A˚2 compared to an
average B-factor = 26.24 A˚2 for all five other strychnine molecules,
indicating that the additional strychnine molecule has a more
disordered binding mode. The first strychnine molecule, which
contacts the (+) face, is pivoted by 48u around the N-atom relative
to the strychnine molecule in all other four binding sites
(Figure 2C, single occupancy in yellow and double occupancy in
magenta). The second strychnine molecule, which contacts the (2)
face, is stacked onto the first molecule in a mirrored upside-down
orientation and both molecules are separated by a distance of
3.6 A˚ (Figure 2B). In the binding site with double occupancy, the
tip of loop C is displaced outward by a distance of 5.6 A˚ relative to
the binding sites with single occupancy (Figure 2C).
Together, these results show that strychnine molecules, which
have a rigid structure, can adopt very distinct but fixed binding
orientations in each of the five binding pockets. For the first time
we observe the presence of two ligands in the binding pocket of
AChBP. Because the C-loop interacting with 2 strychnine
molecules also interfaces with a C-loop from a neighboring
pentamer the double strychnine occupancy might be the result of a
crystal contact. However, interactions between neighboring
pentamers comparable to those observed for AChBP may also
occur under physiological conditions for intact GlyR and nAChR
since these receptors are densely clustered at the neuronal synapse
[29,30].
We also determined the co-crystal structure of Aplysia AChBP in
complex with d-TC in order to verify whether multiple
occupancies and distinct ligand orientations are a common
Author Summary
Ligand-gated ion channels play an important role in fast
electrochemical signaling in the brain. Cys-loop receptors
are a class of pentameric ligand-gated ion channels that
are activated by specific neurotransmitters, including
acetylcholine (ACh), serotonin (5-HT), glycine (Gly), and c-
aminobutyric acid (GABA). Each type of cys-loop receptor
contains an extracellular domain that specifically recog-
nizes only one of these four neurotransmitters and opens
an ion-conducting channel pore upon ligand binding. In
this study, we investigated the poor specificity with which
two potent neurotoxic inhibitors, namely strychnine and d-
tubocurarine, are recognized by different cys-loop recep-
tors. Using X-ray crystallography we solved 3-dimensional
structures of strychnine or d-tubocurarine in complex with
ACh binding protein (AChBP), a well-recognized structural
homolog of the nicotinic ACh receptor. Based on ligand-
receptor interactions observed in AChBP structures we
designed mutant GlyR and a7 nAChR to identify hot spots
in the binding pocket of these receptors that define potent
inhibition by strychnine and d-tubocurarine, respectively.
Combined, our results offer detailed understanding of the
molecular recognition of antagonists that have high
affinity but poor specificity for different cys-loop receptors.
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property among these alkaloid antagonists. The structure of this
complex was solved from diffraction data to 2.0 A˚. The
asymmetric unit contains two pentamers, which interact through
loop C and form an interface that resembles the one seen in the
strychnine complex (Figure 2D). Inspection of simple difference
electron density revealed occupancy of most of the binding sites by
d-TC. Remarkably, at least three different binding orientations of
d-TC can be distinguished (indicated with binding mode 1–3,
Figure 2D). Binding mode 1 (yellow, Figure 2E) occurs at most
binding sites, but with ligand occupancies that vary between 30%
and 60%. d-TC molecules were not built in binding sites if the
electron density indicated partial occupancy. The binding
orientation for these ligands likely corresponds to binding mode
1 but were left unlabeled in Figure 2D. In binding mode 1, the
tertiary amine group of d-TC forms a hydrogen bond with the
carbonyl oxygen of W145 and forms cation-p interactions with
conserved aromatic residues of the binding pocket.
A second ligand orientation (mode 2, magenta, Figure 2E)
occurs only once in the pentamer and is characterized by a polar
interaction between the quaternary amine group of d-TC and the
carbonyl oxygen of W145. In addition to the upside-down
orientation relative to binding mode 1, this ligand is also rotated
by 74u toward the (+) face. A superposition of the (+) face in
binding mode 1 (protein shown in yellow, Figure 2E) and the (+)
face in binding mode 2 (protein and ligand shown in magenta,
Figure 2E) shows that the different ligand orientation in mode 2
results in an outward displacement of the tip of loop C by a
distance of 4.5 A˚ relative to mode 1. Finally, difference electron
density at one of the binding sites involved in a crystal contact
between neighboring C loops indicates the occupancy by a single
ligand likely adopting multiple binding orientations. This ligand
could be acceptably built into the clearest part of the density and is
represented as binding mode 3 (shown in green, Figure 2E). This
ligand is rotated by 140u around the tertiary isoquinoline moiety
relative to d-TC in binding mode 1.
Together, these data demonstrate that rigid molecules like d-TC
and strychnine can adopt different binding orientations in each of
the five equivalent binding sites of the receptor. Loop C, which
forms part of the binding site, adopts a more contracted or
extended conformational state depending on the binding orienta-
tion of the ligand, also when not involved in a crystal contact.
Remarkably, this stabilizes AChBP in a structurally asymmetric
state even though this pentameric protein is composed of identical
subunits. These data imply that potentially a level of functional
diversity of CLRs may arise, which depends on receptor
occupancy, and that would add to diversity arising from
homomeric and heteromeric assemblies of the a- and non-a
subunits bearing intrinsic pharmacological differences.
The conformational state of loop C and its contraction around
the ligand was quantified by measuring the distance between the
carbonyl oxygen atom of W145 and the c-sulfur atom of C188 in
each subunit of the pentamer. In the strychnine complex this
average distance is 9.9061.59 A˚, compared to 11.8061.32 A˚ in
the complex with d-TC (indicated with an asterisk in Figure 3A).
For epibatidine, an agonist for the nAChRs, this distance is
6.8860.16 A˚ and for a-conotoxin ImI, a subtype-specific
antagonist for nAChRs, this distance is 14.3860.13 A˚ (Figure 3A
and 3B). A comparative analysis of C-loop conformations for all
agonists, partial agonists, and antagonists currently co-crystallized
with AChBP reveals several features. First, for most ligands a
correlation exists between the extent of C-loop closure observed in
AChBP structures and the ligand mode of action at nAChRs.
Ligands that act as antagonists (shown in red bars) typically
displace loop C outward by a distance of 10–15 A˚ relative to the
conserved Trp of loop A, whereas agonists (shown in green bars)
cause a contraction of loop C around the ligand and reduce this
relative distance to ,8 A˚. Second, partial agonists cause an
intermediate contraction of 8–10 A˚ and typically induce larger
variations in the extent of C-loop contraction in different subunits
of the pentamer when compared to full agonists and antagonists.
This variation can at least in part be explained by the occurrence
of different ligand orientations for partial agonists [31]. Third, the
position of the C-loop is not a strict predictor for the ligand mode
of action at nAChRs because the C-loop closure for some partial
agonists overlaps the diffuse boundaries that define agonists versus
antagonists (e.g. DMXBA and 4OH-DMXBA). Additionally,
lobeline, which acts as a partial agonist at nAChRs [32], causes
an exceptionally strong C-loop closure. Together, this comparative
analysis rationalizes results obtained from more than 30 co-crystal
structures of AChBPs determined to date and shows in general a
good correlation between C-loop contraction and predicted ligand
action at nAChRs. Finally, multiple ligand orientations are not an
exclusive property of partial agonists as suggested by Hibbs et al.
(2009) [31] because antagonists such as strychnine and d-TC also
show multiple conformations.
Figure 1. Introduction. (A) Structure formulas of strychnine and d-
tubocurarine (d-TC). (B) Cartoon representation of the acetylcholine
binding site in AChBP, which consists of the principal (+) face and
complementary (2) face. Different colors are used to highlight loops
that form the binding site: loop A (red), B (green), C (yellow), D
(magenta), E (blue), and F (orange). Individual residues contributing to
loops A–F are indicated according to their numbering in Aplysia AChBP.
doi:10.1371/journal.pbio.1001034.g001
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Detailed Analysis of the Ligand-AChBP Contacts and
Functional Characterization of Contact Mutants in
Human CLRs
Next, we examined the molecular contacts between ligand and
receptor in more detail, and these results were compared for
strychnine and d-TC. First, strychnine forms contacts with the
following residues on the (+) face: Y91, S144, W145, C188, C189,
Y193 and (2) face: Y53, Q55, M114, I116, D162, S165 (Figure 4A,
Table S2). Three additional contacts are formed in the binding site
with double ligand occupancy, namely Y186 on the (+) face and
T34, R57 on the (2) face (Figure 4B). In comparison, d-TC forms
contacts that are remarkably similar. In binding mode 1 (Figure 4C,
Table S2), d-TC interacts with Y91, S144, W145, C188, C189,
Y186, and Y193 on the (+) face. An additional hydrogen bond is
formed with E191, an interaction not seen in the strychnine-
complex. On the (2) face d-TC forms contacts with T34, Y53, Q55,
M114, I116, and S165 (Figure 4C). In binding mode 2, d-TC forms
an additional hydrogen bond with K141 on the (+) face. Due to the
different ligand orientations, two hydrogen bonds are formed with
Y193 and Q55 (Figure 4D). These findings demonstrate that
strychnine and d-TC, which differ in chemical and three-
dimensional structure, have a large overlap in molecular contacts
in the AChBP binding pocket. Also, the set of interactions formed by
strychnine and d-TC has a much wider range compared to the
agonist nicotine (Table S2), which interacts with Y89, W143, T144,
C187, and C188 on the (+) face and W53, L112, and M114 on the
(2) face (residues and numbering correspond to the Lymnaea AChBP
complex with nicotine, pdb code 1uw6).
Comparison with residue contacts formed by a-conotoxin ImI,
which has high selectivity for distinct nAChR-subtypes (pdb code
2c9t [33]), demonstrates that this peptide antagonist forms residue
contacts that overlap with interactions seen for strychnine and d-
TC but extend to a much wider range of residues (Table S2). a-
Conotoxin ImI forms contacts with the (+) face: Y91, S144, W145,
V146, Y147, Y186, C188, C189, E191, Y193, and I194 (exclusive
contacts are underlined). On the (2) face contacts are formed with
Y53, Q55, R57, D75, R77, V106, T108, M114, I116, D162, and
S164. Thus, the high subtype-selectivity of a-conotoxin ImI likely
arises from a broad range of contacts that are only found in
specific nAChR subtypes [33]. In contrast, the poorly selective
recognition of strychnine and d-TC may arise from similar
interactions in binding pockets of different CLRs. For example,
residues of loop A and loop C show good sequence conservation
among most members of the CLR family. Specifically for loop E,
residues homologous to M114 and/or I116 are well conserved
between the a7 nAChR (Q117) and 5-HT3R (Q123), which are
both inhibited by d-TC. Good conservation also exists between the
a1 GlyR (L127/S129) and a1 GABAA-R (L128/T130), which are
both inhibited by strychnine.
Are the observed ligand orientations and molecular contacts in
AChBP representative for our understanding of antagonist
recognition in human CLRs? To address this question, we
performed alanine-scanning mutagenesis of the homologous
residues in the human GlyR or nAChR using structure-based
sequence alignments with AChBP (see Figure S1). The two-
electrode voltage-clamp technique was used to measure ligand
potency on wild type and mutant GlyR or nAChR expressed in
Xenopus oocytes. For strychnine, we characterized homologous
contact mutants in the human a1 GlyR because it is the primary
target that mediates the physiological effects of strychnine. Results
of this comprehensive mutagenesis study are summarized in
Table 2. We found that strychnine displays a decrease in potency
for most a1 GlyR mutants by 1–2 orders of magnitude. F159A
and F214A were not functional. Critical contact residues are
located in loop B (S158, homologous to S144 in AChBP) and loop
D (F63 and R65, homologous to Y53 and Q55 in AChBP,
respectively). Mutation of residue S158 in loop B of the GlyR (this
study) causes a 300-fold decrease in strychnine-potency, whereas
mutation F63A and R65A in loop D [23] cause a 250- and 3-fold
decrease in strychnine-potency, respectively. Additionally, muta-
tion of contacts in loop A (A101, homologous to Y91-AChBP) and
loop E (L127 and S129, homologous to M114- and I116-AChBP)
cause a ,10-fold drop in potency. Mutation of Q177 in loop F
(homologous to D162-AChBP) causes an apparent increase in
strychnine-potency. To investigate the relevance of two strychnine
molecules occupying a single binding pocket we investigated the
effect of mutations at positions homologous to residues involved in
unique contacts in the double strychnine occupancy mode, namely
T34, R57, and Y186 in AChBP. The IC50-values for the
homologous mutants in the a1 GlyR, F44A, and Q67A and
F207A, are 3-, 15-, and 119,444-fold higher than wild type
receptor, respectively. One of these mutants, F207A, was
previously characterized in the work from Grundzinska et al.
[23]. Such a profound effect of F207A could be expected if the
interactions occur as observed for the first strychnine molecule
under double occupancy binding mode. The profound effects of
these mutations on strychnine inhibition, in particular F207A,
suggest that the double occupancy binding mode of strychnine as
observed in the crystal structure is biologically relevant.
For d-TC, previous mutagenesis studies have been carried out
either on the muscle-type nAChR [1] or 5-HT3R [5,12]. The
heteropentameric muscle-type nAChR contains two different
binding sites for d-TC with a 100-fold difference in affinity, whereas
differences between human and mouse 5-HT3R yield a more than
1,000-fold difference in affinity. Both model systems either
complicate the mutational analysis or make it difficult to derive
conclusions that can be generalized to other CLRs. Here, we chose
the human a7 nAChR to characterize the effect of homologous
contact mutations on the potency of d-TC. The a7 nAChR, which is
also a target of d-TC [4], is closely related to Ac-AChBP and is an
attractive model system to extrapolate the results obtained from our
X-ray crystal structures. Fifteen potential contacts in a7 nAChR
were mutated and seven of these yielded a non-functional receptor,
most of which are mutants of loop C. Similar to strychnine, crucial
contacts are localized in loop B (S148, homologous to S144-AChBP)
and loop D (W55, homologous to Y53-AChBP), which display a
148-fold and 14-fold drop in d-TC-potency, respectively. Mutations
in other loops of the a7 nAChR have moderate to no effect (S36A,
Y93A, Q117A, L119A, and E193A—homologous to T34-, Y91-,
M114-, I116-, and E191-AChBP). Two mutants, namely G167A in
Table 1. Binding properties of strychnine and d-TC on
different CLRs.
Ki Strychnine (nM) Ki d-Tubocurarine (nM)
Ac-AChBP 38.063.3 509.2638.0
Ls-AChBP 223.5626.3 170.7618.3
human a7 nAChR 4,8546133 2,9756378
human a1 GlyR 1662a ND
mouse 5-HT3R ND 138622
b
Binding constants were determined using competitive binding assays with 3H-
epibatidine or 3H-methyllicaconitine (see Text S1). ND, not determined.
a,bBinding constants for strychnine on human a1 GlyR (a) and d-TC on mouse 5-
HT3R (
b) were taken from previous studies [28,40].
doi:10.1371/journal.pbio.1001034.t001
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the a7 nAChR and Q177A in the a1 GlyR (homologous to D162-
AChBP), showed a significant decrease in the IC50-values for d-TC
or strychnine compared to the wild-type receptor (p,0.05). A
possible explanation for this observation is that these ligand
interactions are energetically unfavorable in the wild type receptors.
Together, these AChBP-directed mutagenesis analyses pinpoint
crucial interactions of strychnine and d-TC to residues in loop B
and loop D of the a1 GlyR and a7 nAChR. This indicates that
strychnine and d-TC form similar interactions in different classes of
CLRs, which parallels our observation from the X-ray crystal
structures with AChBP.
Molecular Dynamics Simulation of AChBP Complexes
X-ray crystal structures of AChBP provide static snapshots of a
receptor that undergoes highly dynamic changes upon ligand
binding [34]. To investigate the validity of AChBP crystal
structures and their different ligand binding modes observed in
this study, we simulated the dynamic behavior of AChBP
complexes with strychnine and d-TC and compared the calculated
ligand orientations with those observed in co-crystal structures of
AChBP. Simulation of an interface occupied either by a single
strychnine molecule or two strychnine molecules shows that the
system quickly resolves to equilibrium, indicating that a thermo-
dynamically equilibrated conformation is obtained. Introduction
of the ligand into an equilibrated conformation of the unliganded
AChBP demonstrates that an induced fit is obtained within 9 to
12 ns (available as Movie S1). Superposition of simulated
conformations and X-ray crystal structures showed only subtle
changes characterized by an RMSD = 1.6 A˚ for strychnine in
single occupancy, 1.8 A˚ for strychnine in double occupancy, 1.4 A˚
for d-TC in binding mode 1, and 3.2 A˚ for d-TC in binding mode 2
(Figure S2, panel A, B, and C).
Additionally, the system equilibrium was evaluated for each
simulation as described in [35]. The equilibrium timeframe was
truncated by 3 ns from the beginning along the time coordinate to
avoid boundary artifacts. Interaction energy was measured for the
ligand using thermodynamic integration in one direction along the
time coordinate, giving 1261 kJ/mol for the single strychnine
conformation, 261061 kJ/mol for double strychnine conforma-
tion, 1161 kJ/mol for d-TC binding mode 1, and 1061 kJ/mol
for binding mode 2.
We attributed significant differences of the d-TC ligand pose 2
from others in RMSD from crystal structure to failure of H-bond
formation with residue K141 from the (+) interface, which is
observed in the X-ray structure. To investigate this we performed
a more precise QM/MM (B3LYP/CHARMM) simulation.
Details on system setup and simulation procedure are given in
the Text S1 (see also Figure S3). After a 40 ps simulation RMSD
from the crystal structure for the d-TC ligand pose 2 dropped to
around 1.8 A˚ (Figure S2D).
Finally, we measured the fluctuation properties of the
equilibrium state using a direct Fourier transform. Fourier spectra
and the resulting frequency characteristic (Fc) were derived for
AChBP bound to d-TC and strychnine and compared to typical
agonists and antagonists. The primary frequency characteristic for
unliganded AChBP was located at 450615 GHz, whereas the
complex with d-TC exhibited a leftward shift to 212630 GHz,
indicative of lower oscillation energy (Figure 5). This shift can be
interpreted as a decrease in the thermodynamic temperature,
which leads to an increased stability of the complex. A comparable
leftward shift (Fc = 105615 GHz) was observed in a control
simulation performed for AChBP in complex with a variant of a-
conotoxin PnIA (pdb code 2br8). In contrast, AChBP in complex
with nicotine (pdb code 1uw6) demonstrated an extreme rightward
shift (Fc = 1,2006550 GHz). The partial agonist tropisetron also
demonstrated a slight increase in oscillation frequency
(Fc = 745650 GHz). These data suggest a correlation between a
leftward shift of Fc and antagonistic action of the ligand and a
rightward shift and agonist activity. This increase in thermody-
namic temperature upon agonist binding agrees well with previous
findings that agonist potency is correlated with increase in domain
mobility upon ligand binding [31,36] and indicates a higher
flexibility of AChBP compared to complexes with antagonists.
Unexpectedly, the AChBP-complex with strychnine exhibits a
small increase in oscillation frequency up to 655630 GHz
(Figure 5). This result parallels our analysis of the conformational
states of loop C (Figure 3), showing that strychnine stabilizes loop
C in a conformation similar to some agonists.
In summary, we found that deviations of the crystal structures
from the simulated energy minimum are relatively small. All ligand
conformations induce receptor fit with high energy, thereby
increasing binding efficacy and reducing the probability to switch
from one conformation to another. Analysis of the oscillatory
movement of AChBP shows that agonist binding results in a
thermodynamic destabilization of the receptor, whereas antagonist
binding freezes AChBP in a state with a lower oscillation frequency.
In conclusion, using molecular dynamics we observe distinct
binding modes that are present in the AChBP model system and
that might correspond to binding poses present in CLRs.
Discussion
Acetylcholine binding protein (AChBP) has proven a valuable
tool for structural studies with more than 20 prototypical ligands
for the nAChR. In this study, we take advantage of the molecular
recognition by AChBP of strychnine, a prototypical antagonist for
Figure 2. X-ray crystal structures of AChBP complexes with strychnine and d-tubocurarine. (A) Crystal structure of Aplysia AChBP in
complex with strychnine as seen along the 5-fold symmetry axis. The asymmetric unit contains 1 pentamer, which interacts with a neighboring
pentamer in the crystal packing through an interaction that involves 2 C-loops. At one of these C-loops the ligand binding pocket is occupied by 2
strychnine molecules (indicated with ‘2’). All 4 other binding pockets contain a single strychnine molecule (indicated with ‘1’). (B) Electron density for
strychnine molecules. 2Fo2Fc density for single occupancy was contoured at 1.5 sigma, and for double occupancy the sigma level was 0.8. Ligands
are shown perpendicular to the 5-fold symmetry axis. (C) Superposition of the 2 binding modes that occur in the AChBP-strychnine complex. The
yellow model shows a detailed view of a principal subunit with a single strychnine molecule bound, and the magenta model shows occupancy by
two strychnine molecules. Double occupancy results in an outward movement of loop C by 5.6 A˚ and a rotation of one strychnine molecule around
the N-atom involved in the hydrogen bond with the W145 carbonyl. (D) Crystal structure of Aplysia AChBP in complex with d-TC as seen along the 5-
fold symmetry axis. The asymmetric unit contains 2 pentamers, which also interact through an interface formed by 2 neighboring C-loops. The 10
ligand binding pockets are characterized by the occupancy of d-TC molecules in 3 different binding orientations. The predominant binding mode is
binding mode 1, which is present in most binding pockets, but with varying degree of ligand occupancy. Only sites with full occupancy of binding
mode 1 are indicated with ‘1.’ Ligands in binding modes 2 and 3 have full occupancy and occur only once. Electron density for d-TC molecules is
shown as 2Fo2Fc density contoured at a sigma level of 1. (E) Comparison of different ligand orientations for d-TC relative to the principal subunits.
Binding mode 1 is shown in yellow, mode 2 in magenta, and mode 3 in green. Occupancy of d-TC in binding mode 2 results in a relative outward
displacement of loop C by 4.5 A˚ compared to binding mode 1.
doi:10.1371/journal.pbio.1001034.g002
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the GlyR, and d-TC, which acts on the nAChR and 5-HT3R. We
determined X-ray crystal structures of strychnine or d-TC
complexes with AChBP and quantified the energetic contribution
of observed interactions using molecular dynamic simulation and
mutagenesis in a1 GlyR and a7 nAChR. Our results demonstrate
that AChBP binds strychnine and d-TC with high affinity and
serves as an appropriate model for mapping the binding site
topography in different CLRs, including the GlyR, nAChR, and
5-HT3R.
In the AChBP complex with strychnine we observed that four
binding pockets are fully occupied by a single ligand in identical
binding orientations. A fifth binding pocket, which is also involved
in a crystal contact, is occupied by two strychnine molecules in a
different binding orientation. The relevance of the double
occupancy in the binding sites of AChBP to true CLRs is not
entirely clear. An intriguing possibility is that double ligand
occupancy, which occurs at an interface between two neighboring
AChBP molecules, may also occur at synapses where native CLRs
Figure 3. Comparative analysis of C-loop conformation. (A) For each AChBP crystal structure determined to date we quantified the closure of
loop C as the distance between the carbonyl oxygen of the conserved Trp residue of loop A and the sulfur atom of the first cysteine involved in the
vicinal disulfide bridge formation (W145 and C188 in Ac-AChBP, W143 and C187 in Ls-AChBP, and W142 and C186 in Bt-AChBP). Bars are colored
according to the mode of action of each ligand on nAChRs (agonist, green; partial agonist, blue; antagonist, red; unknown, white). Space fill models
are shown for selected ligands. Surface representations were used for a-cobratoxin and a-conotoxin PnIA (A10L, D14K). C-loop conformation for
strychnine and d-TC complexes are indicated with *. (B) Superposition of crystal structures of a prototype agonist (epibatidine), partial agonist
(tropisetron), and antagonist (a-conotoxin). The dashed lines indicate the distance measure, which is plotted in panel A. The scale bar on the right
gives a visually intuitive interpretation of the mode of action for a compound based on C-loop closure. The C-loop contraction for the 2 co-crystal
structures reported in this study is indicated with arrows.
doi:10.1371/journal.pbio.1001034.g003
Figure 4. Structural recognition of strychnine and d-tubocurarine in AChBP. (A) Detailed view of the ligand binding pocket for single
occupancy by strychnine. Principal face (yellow) and complementary face (blue) are shown in ribbon representation. Amino acids involved in ligand-
receptor contacts are shown in sticks. (B) Same as in (A) for double occupancy by strychnine. The same amino acids as in (A) are involved in contacts,
except for 3 additional contacts formed by Y186, R57, and T34. (C) Detailed view of the amino acids involved in ligand-receptor interactions with d-TC
in binding mode 1. Principal subunit is shown in yellow ribbon and complementary subunit in blue ribbon representation. (D) Detailed view of amino
acids forming ligand-receptor contacts for d-TC in binding mode 2. The same residues as in (C) are involved except an additional contact with K141 is
formed. Black dashed lines indicate hydrogen bonds. The white dashed line in panel D indicates a polar interaction between the quaternary amine
group of d-TC and the carbonyl oxygen of W145.
doi:10.1371/journal.pbio.1001034.g004
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are tightly clustered. In analogy, four molecules of epibatidine
were suggested to be present in the muscle-type nAChR with its
two expected binding sites [37].
In the AChBP complex with d-TC we observed that a preferred
ligand orientation occurs in most binding pockets, but with varying
degrees of occupancy. Two other binding pockets contain a ligand in
a different orientation at full occupancy or a ligand that appears to
switch between 2 orientations in a single site. Consequently, these
different ligand binding modes result in varying conformations of
loop C and stabilize the homopentameric AChBP in a structurally
asymmetric state. This adds a new level of diversity among CLRs,
whose heterogeneity is known to arise from homomeric and
heteromeric assemblies of a- and non-a subunits with different
pharmacological properties. Multiple orientations of the same ligand
in binding sites of the same AChBP molecule revealed in our work
may be present in complexes with true CLRs [38].
Our energy calculations of AChBP complexes, in combination
with mutagenesis experiments on the a1 GlyR and a7 nAChR,
point to crucial interactions with residues in loop A (Y91-AChBP), B
(S144- and W145-AChBP), and D (Y53-AChBP). Gao et al. [24]
investigated d-TC and metocurine binding modes using computa-
tional methods available at that time and proposed residues Y89
(loop A), W143 (loop B), Y192 (loop C), and L112 and M114 (loop
E) in Lymnaea AChBP to be structural determinants of d-TC binding.
Grudzinska et al. [23] simulated docking of strychnine into a
homology model of the a1 GlyR and identified several residues
crucial for strychnine-affinity, including F63 (loop D) and R131
(loop E). Some of these ligand contacts identified in both studies are
confirmed by our results, but the overall ligand orientation of the
strychnine and d-TC molecules modeled using computational
approaches differs from those observed in our X-ray crystal
structures and MD simulations. Moreover, we have systematically
mutated the homologous contact residues in all loops of the a1 GlyR
and a7 nAChR, based on ligand binding poses experimentally
observed in X-ray crystal structures of AChBP. This allowed us to
derive a common mode of action that defines poor selective
recognition of strychnine and d-TC by various CLRs.
The essential residues in loop A, B, and D as identified in our
study belong to the aromatic residues that are highly conserved
among the CLR family, possibly explaining the wide range of
CLRs that can be targeted by strychnine and d-TC. In contrast,
peptide neurotoxins form an overlapping but more extended range
of interactions with the principal and complementary faces of the
binding site. This is clear upon comparison with the subtype-
Table 2. Summary of alanine-scanning mutagenesis for homologous contact residues in the a1 GlyR and a7 nAChR.
Strychnine d-Tubocurarine
Ac-AChBP a1 GlyR IC50 (nM) mut/wt a7 nAChR IC50 (mM) mut/wt
wt 46.868.75 Wt 1.1960.17
Principal side
loop A
Y91 A101F 583647.6 12 Y93A 7.8160.98 6.6
loop B
K141 K145A NC
S144 S158A 13,80061,410 294 S148A 176610.8 148
W145 F159A NC W149A NC
loop C
Y186 F207Aa 5.5961.89 mM 119,444 Y188A NC
C188 C209A NC C190A NC
C189 I210A 103619 2.2 C191A NC
E191 E193A 8.1060.68 6.8
Y193 F214A NC Y195A NC
Complementary side
loop D
T34 F44Aa 13064.06 2.8 S36A 2.2560.52 2
Y53 F63A 12,00063,000b 256 W55A 16.760.94 14
Q55 R65A 160650b 3.4 Q57A NC
R57 Q67Aa 6896176 14.7
loop E
M114 L127A 376669.2 8 Q117A 2.2860.14 1.9
I116 S129A 3586144 8 L119A 9.1962.16 7.7
loop F
D162 Q177A 3.3660.63 0.1 G167A 0.04360.002 0.03
The two-electrode voltage clamp technique was used to measure the affinity of strychnine on d-TC for mutants of the a1 GlyR and a7 nAChR, respectively. Structure-
based sequence alignments were calculated and residues homologous to those involved in ligand interactions in AChBP structures were mutated to Ala. The Ala residue
at position 101 in the a1 GlyR (homologous to Y91 in Ac-AChBP) was mutated to F. NC, no current.
aResidues that form unique contacts with strychnine in double ligand occupancy mode.
bIC50-values obtained from Grudzinska et al. [23].
doi:10.1371/journal.pbio.1001034.t002
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specific antagonist of nAChRs, a-conotoxin ImI. However,
peptide toxins and smaller antagonists like d-TC and strychnine
share a similar molecular mechanism of action: both classes of
antagonists stabilize loop C in a similar extended conformation.
Notably, for the ligands characterized in this study there is a
significant correlation between C-loop closure observed in AChBP
crystal structures, molecular dynamics equilibrium, and the
frequency that characterizes AChBP oscillation. Thus, we propose
that the conformation of loop C and the induced oscillation of the
extracellular domain arise from residue interactions in the ligand-
binding site. Combined, the effects on C-loop extension reflect the
intrinsic properties of any given ligand and therefore predict well
its type of action. We suggest that antagonist effects are
transmitted through a thermodynamic stabilization of the
extracellular domain and arise from a limited range of residue
contacts as shown for strychnine and d-TC. These defined ligand-
receptor interactions are found for homologous residues in
different CLRs and likely explain the low selective antagonism
of strychnine and d-TC.
Materials and Methods
Co-Crystallization of AChBP with Strychnine and d-TC
Aplysia AChBP was expressed and purified from Sf9 insect cells
as previously published [25]. Strychnine and d-TC were obtained
from Sigma and co-crystallized at a concentration of 1–5 mM.
Crystals for Ac-AChBP+ strychnine were grown in 200 mM
sodium acetate, 100 mM bistrispropane at pH 8.5, 15.5%
PEG3350. Crystallization conditions for Ac-AChBP+d-TC were
200 mM Na2SO4, 100 mM bistrispropane at pH 8.5, 15%
PEG3350. Growth of crystals at 4 uC was essential to obtain
good diffraction for both complexes. Cryoprotection was achieved
by adding glycerol to the mother liquor in 5% increments to a final
concentration of 30%. Crystals were flash-cooled by immersion in
liquid nitrogen. Diffraction data processing was done with
MOSFLM and the CCP4 program suite. The structure was
solved by molecular replacement using MOLREP. Automated
model building was carried out with ARP/wARP and refinement
was done with REFMAC or PHENIX with TLS and NCS
restraints. Manual building was done with COOT and validation
of the final model was carried out with MOLPROBITY. All
model figures were prepared with PYMOL.
Pharmacological Characterization of AChBP, Mutant a1
GlyR and a7 nAChRs
Competitive binding assays with 3H-epibatidine were carried
out as previously published with minor modifications (see Text
S1). Electrophysiological assays were carried out using the two-
electrode voltage clamp technique. The cDNA encoding human
a1 GlyR was subcloned into pGEM-HE for oocyte expression
with a PCR strategy and verified by sequencing. The cDNA was
linearized with NheI and transcribed with the T7 mMessage
mMachine kit from Ambion. The cDNA encoding the human a7
nAChR was cloned into pMXT and linearized with BamHI for
transcription with the SP6 mMessage mMachine kit from
Ambion. All mutants were engineered using a Quikchange
method (Stratagene) and verified by sequencing. Recordings were
obtained from oocytes 2–5 d after injection with 50 nl of ,1 ng/
nl RNA. For the determination of IC50-values varying concen-
trations of strychnine or d-TC were co-applied with EC50-
concentrations of glycine or acetylcholine, respectively. Peak
current responses in the presence of increasing concentrations of
strychnine or d-TC were averaged and the mean 6 s.e.m.
analyzed by non-linear regression using a logistic equation
(GraphPad Prism 5). Student’s t test was used for statistical
comparison of paired observations.
Molecular Dynamics and Docking Simulations
Sequence analysis was performed with the ClustalW2 algo-
rithm. Homology models of the a1 GlyR and a7 nAChR were
used to verify our mutagenesis strategy, which was based on
predictions from sequence alignments. Modeller9v6 was used
without any GUI software and protein structures with pdb code
2vl0 and 2bg9 as templates. Energy for all models was minimized
with CHARMM27. Docking was performed in AUTODOCK4
with 32 flexible bonds in receptor selected from residues inside a
sphere r = 5A˚ centered at mass center of the ligand in the
corresponding X-ray structure. A full description of molecular
dynamic simulation methods is given in Text S1. Molecular
analysis and visualization was performed in UCSF Chimera and
PyMol. For video editing AVS Video Editor was used.
Accession Numbers
Protein Data Bank accession codes for previously published X-
ray crystal structures are: Ac-AChBP in complex with lobeline
(2bys), epibatidine (2byq), imidacloprid (3c79), thiacloprid (3c84),
HEPES (2br7), polyethyleneglycol (2byn), DMXBA (2wnj), 4OH-
DMXBA (2wn9), cocaine (2pgz), anabaseine (2wnl), in silico
compound 31 (2w8f), MLA (2byr), in silico compound 35 (2w8g),
sulfates (3gua), a-conotoxin ImI (2c9t and 2byp), a-conotoxin
PnIA variant (2br8), a-conotoxin TxIA (2uz6), apo state (2w8e),
Y53C-MMTS (2xz5) with acetylcholine, Y53C-MTSET (2xz6).
Bt-AChBP in complex with CAPS (2bj0) and Ls-AChBP in
complex with nicotine (1uw6), clothianidin (2zjv), HEPES (1ux2),
carbamylcholine (1uv6), imidacloprid (2zju), a-cobratoxin (1yi5).
Monomeric extracellular domain from mouse a1 nAChR in
complex with a-bungarotoxin (2qc1).
Structures of Ac-AChBP in complex with strychnine (2xys) and
d-tubocurarine (2xyt) were obtained during this study.
Figure 5. Correlation between a fast oscillatory movement of
AChBP and C-loop closure. Analysis of the oscillatory frequency (Fc)
that describes the movement of AChBP during a molecular dynamic
simulation for complexes with strychnine, d-TC, and typical agonists and
antagonists for the nAChR. Complexes with agonists (nicotine) show a
higher oscillation frequency (shown as grey bars) than antagonists (d-TC
and PnIA). A good correlation exists with C-loop closure (same data as
in Figure 3A, shown as white squares). No data are shown for C-loop
closure of the unliganded state because the C-loop was disordered in
our X-ray crystal structure of the apo form (pdb code 2w8e).
doi:10.1371/journal.pbio.1001034.g005
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PubChem coordinates: strychnine (441,071) and d-tubocurarine
(6,000).
Supporting Information
Figure S1 Topology of the AChBP binding pocket and
homologous residues in other CLRs. (A) Surface representation
of the AChBP binding pocket. Residues from loop C (185–193)
were omitted for clarity. Ligand contacts that are common to
strychnine and d-tubocurarine were color coded according to
importance in the mutagenesis analysis in Table 2: essential (red),
important (green). and less important (blue). (B) Sequence
alignment of AChBPs, glycine receptors, and nicotinic acetylcho-
line receptors. Structure-based sequence alignments were calcu-
lated using secondary structure matching (SSM) for AChBPs from
different species and the structure for the monomeric mouse a1
nAChR extracellular domain [39]. This alignment was separately
seeded with human GlyR/GABAAR and nAChRs/5-HT3R
sequences, respectively, and aligned in ClustalW. Both alignments
were then merged with manual adjustments for loop F and loop C.
Amino acids involved in ligand-receptor contacts in the strych-
nine- and d-tubocurarine-bound structures are indicated in black.
In our study, homologous positions in human a1 GlyR and human
a7 nAChR were mutated to alanine, except for a1 GlyR Ala101,
which was mutated to phenylalanine. (1) indicates residues that
only form contacts with strychnine, and (2) indicates a residue that
only forms contacts with d-tubocurarine.
(TIF)
Figure S2 Panels A and B compare the AChBP conformations
after energetic minimization with molecular dynamic simulation for
strychnine complexes with single occupancy (A) and double
occupancy (B). The unliganded protein equilibrium state is shown
in cyan, X-ray crystal structure in magenta, liganded equilibrium
state in yellow. Panels C and D compare the AChBP simulated
conformations for d-tubocurarine complexes with binding mode 1
(C) and mode 2 (D). The same color codes are used as in (A) and (B).
(TIF)
Figure S3 Setup of classical simulations. Protein was simulated
as a complete pentamer with a single ligand bound. A 9 nm3
solvation cube consisting of 38,256 SPC water molecules was
applied centered at the center of the protein (halfway from upper
lumen at the axis of radial symmetry).
(TIF)
Movie S1 Induced fit of strychnine and d-tubocurarine in Aplysia
AChBP.
(MOV)
Table S1 Crystallographic and model refinement statistics.
(PDF)
Table S2 Comparison of residue contacts observed in crystal
structures of AChBP in complex with a-conotoxin ImI, strychnine,
d-tubocurarine, and nicotine. (*) indicates residues that are unique
contacts for strychnine in double occupancy of the binding pocket.
(#) contact residues for the nicotine bound-structure of Lymnaea
AChBP are indicated according to homologous residues for Aplysia
AChBP (first column).
(PDF)
Text S1 Supplementary methods.
(DOC)
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